(Q40018278)

English

A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells

scientific article published on 31 January 2008

Statements

A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells (English)
0 references
0 references
0 references
0 references
0 references
Adriana Lombardi
Giulia Cantini
Elisabetta Piscitelli
Stefania Gelmini
Michela Francalanci
Gianni Forti
Mario Rotondi
Mario Serio
31 January 2008
718-724

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit